LillianCare, a pioneering healthcare company based in Berlin, dedicated to tackling Germany’s critical physician shortage, proudly announces the successful completion of a €1.5 million extension funding round. This achievement reflects robust investor confidence in LillianCare’s mission and innovative approach to healthcare delivery.
Strong backing from existing investors
Leading the extension funding round were Nina Capital and caesar., both reaffirming their commitment to LillianCare’s vision. They were joined by other established investors such as Calm/Storm Ventures and Björn von Siemens, who have once again demonstrated their support by reinvesting in the company. This continued backing underscores the investors’ belief in LillianCare’s potential to address urgent healthcare needs in Germany.
“We’ve already seen the positive impact of LillianCare’s two established practices in Nastätten and Neuerburg,” said Marc Subirats, General Partner at Nina Capital. “We are excited to continue supporting their journey and look forward to seeing further practices open across Germany.”
Dr. Carolin Gabor, Managing Partner at caesar., emphasized the critical need for LillianCare’s solutions, stating: “With 4,100 general practitioner positions currently unfilled, the urgency of an innovative solution like LillianCare’s is evident. We are proud to support the team’s mission and look forward to the positive impact they will continue to make.”
New investors bolster LillianCare’s mission
The funding round also attracted several new investors, including Ship2B Ventures, which made a significant investment as a new co-investor. Ship2B’s involvement, through the BSocial Impact Fund supported by the FEI, Banco Sabadell, and AXIS, highlights a strong belief in LillianCare’s commitment to social impact.
“LillianCare’s innovative hybrid practice model and dedication to improving healthcare accessibility resonate deeply with our mission to drive social impact,” said Jordi Ferrer, Investment Director at Ship2B. “We believe their approach will not only provide immediate relief to underserved communities but also set a new standard in the healthcare industry.”
Other notable new investors include Atlantis Ventures, Stefan Menden, Pascal Werner, and Markus Frühwein, a member of LillianCare’s advisory board. Their participation brings additional expertise and validation to LillianCare’s innovative approach.
Innovative solutions for a critical need
Founded in 2023, LillianCare’s platform enables nurses to serve as the first point of physical contact for outpatients with health complaints, performing 60% of all treatments with digital supervision and support from doctors. This approach allows doctors to focus their time and attention on more complex cases. The platform’s data-driven alignment of processes and clinical decisions ensures quality medical care, reintroduces local healthcare to underserved communities where practices have closed and improve working conditions for medical staff.
Linus Drop, CEO and Co-Founder of LillianCare said: “We are humbled and grateful for the continued support from our current investors and excited to welcome new investors who share our vision. This funding will enable us to expand our reach and continue making a positive impact on healthcare accessibility in Germany.”
